J&J MedTech jumps into surgical robot game as OTTAVA secures FDA nod
While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with “select customers”.
While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with “select customers”.
The National Healthtech Access Programme aims to improve accessibility to healthtech products across the NHS.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Intuitive Surgical expands platforms despite market headwind
The increased importance of safety for wearable devices
What does the EU Data Act mean for businesses?
GE HealthCare launches new ultrasound system for cardiovascular imaging